TREATMENT AND MANAGEMENT OF DIABETES WITH STEM CELL THERAPY: A NEWER SCIENTIFIC APPRAOCH

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 4

Abstract

Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood. Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. Patients with high blood sugar will typically experience polyuria (frequent urination); they will become increasingly thirsty (polydipsia) and hungry (polyphagia). Insulin, a hormone produced by the pancreas helps in the control of blood sugar. While Diabetes can be caused by too little insulin, resistance to insulin or both, its treatment becomes mandatory for patients as a large part of the Indian population is gradually being detected with high blood sugar. Stem cells are mother cells that have the potential to become any type of cell in the body. One of the main characteristics of stem cells is their ability to self-renew or multiply while maintaining the potential to develop into other types of cells. Stem cells can become cells of the blood, heart, bones, skin, muscles, brain etc. Within recent years, stem cell research has become a very important part of the scientific understanding of type 1 diabetes. Research has demonstrated that stem cells can be grown in the lab. In 2004, the University of Pittsburgh grew insulin producing beta cells by introducing two genes ‘cdk’ and ‘cyclin d’ via a virus. The researchers were able to deactivate the virus and also prevent stem cells from growing further. The research could lead to a better availability of beta cells for future research purposes. Type 1 and type 2 diabetes results when beta cells in the pancreas fail to produce enough insulin, the hormone that regulates blood sugar. One approach to treating diabetes is to stimulate regeneration of new beta cells. The current short communication elucidate about probable treatment of diabetes with the help of stem cell therapy.

Authors and Affiliations

Prof. Satyanand Tyagi*| President & Founder, Tyagi Pharmacy Association & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074., Patel Chirag J| Editor-in-Chief, Tyagi Pharmacy Association (TPA) & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074., Dr. Ruchika Nandha| Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Chandigarh, Punjab, India-160014., Dr. Kavita Sekhri| Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Chandigarh, Punjab, India-160014., Dr. Suruchi Aditya| Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Chandigarh, Punjab, India-160014., Dr. Ravpreet Singh| P.G. Research Scholar, Department of Homoeopathy, Sri Sai Nath Post Graduate Insti. of Homoeopathy, Allahabad, Uttar Pradesh, India-211002., Anil Kumar Gupta| Research Scholar, Bhagwant University, Institute of Pharmacy & Research Center, Ajmer, Rajasthan, India-305004, Dr. Shweta Tyagi| Sri Sri College of Ayurvedic Science and Research Hospital, Kanakapura Road, Udayapura, Bangalore, Karnataka, India-560082.

Keywords

Related Articles

FORMULATION AND EVALUATION OF BUCCOADHESIVE GEL FOR THE TREATMENT OF ORAL SUBMUCOSAL FIBROSIS

Oral submucosal fibrosis (OSF) is a disease affecting the oral cavity and characterized by chronic, complex, irreversible, potentially malignant disorder (PMD) and crippling condition of oral mucosa, various delivery sys...

A suspected case of diphtheria, pertussis and tetanus vaccine (DPT) induced seizure in a paediatric patient

A 4-month old male child developed convulsions possibly following diptheria, pertusis (whooping cough), and tetanus (DPT) vaccine used for routine immunization. A diagnosis of vaccine induced seizures was made after ruli...

Protective potential of Hesperidin against Diethylnitrosamine induced Hepatocarcinogenesis in rats

The present study was designed to investigate the hepatoprotective activity of hesperidin against Diethylnitrosamine (DENA) induced Phenobarbital (PB) promoted hepatotoxicity in Wistar albino rats. Twenty four male Wista...

Prevalence of anemia among children age 10 to 15 years in urban, Chidambaram

In India, 74% of children and over 50% of adolescent girls and women of reproductive age are anemic.

NOVEL COMPOUNDS WITH ANTIULCEROGENIC POTENTIALS UNVEILED IN PLANTAIN LEAVES ISOLATES (MUSA PARADISCIACA)

Ethanolic extract of plantain leaves was tested on forty eight ethanolic induced gastric ulcer rats for 28 days. The extract was found to posses potent antiulcerogenic effects. The isolates of such was analysed with Nucl...

Download PDF file
  • EP ID EP1375
  • DOI -
  • Views 469
  • Downloads 44

How To Cite

Prof. Satyanand Tyagi*, Patel Chirag J, Dr. Ruchika Nandha, Dr. Kavita Sekhri, Dr. Suruchi Aditya, Dr. Ravpreet Singh, Anil Kumar Gupta, Dr. Shweta Tyagi (2013). TREATMENT AND MANAGEMENT OF DIABETES WITH STEM CELL THERAPY: A NEWER SCIENTIFIC APPRAOCH. Journal of Drug Discovery and Therapeutics, 1(4), 28-33. https://europub.co.uk/articles/-A-1375